- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00520351
Comparison of Lens Care Regimens With a Silicone Hydrogel Lens (Emerald)
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Fase
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L3G1
- Centre for Contact Lens Research, School of Optometry, University of Waterloo.
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
A person is eligible for inclusion in the study if he/she:
- Is at least 17 years of age and has full legal capacity to volunteer.
- Has read, understood and signed an information consent letter.
- Is willing and able to follow instructions and maintain the appointment schedule.
- Is presently using either bi-weekly or monthly replacement lenses.
- Has symptoms of ocular dryness as determined by specific pre-screening criteria.
- Is correctable to a visual acuity of 6/9 or better (in each eye) with their habitual vision correction.
- Has clear corneas and no active ocular disease.
- Has had an ocular examination in the last two years.
Exclusion Criteria:
A person will be excluded from the study if he/she:
- Is an asymptomatic lens wearer.
- Is a daily disposable contact lens wearer.
- Is a current extended wear contact lens wearer.
- Currently uses one of the study lens care regimens.
- Has any clinically significant blepharitis.
- Has undergone corneal refractive surgery.
- Is aphakic.
- Has any active ocular disease.
- Has any systemic disease affecting ocular health.
- Is using any systemic or topical medications that may affect ocular health.
- Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.
- Is participating in any other type of clinical or research study.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: 2
|
contact lens care system
|
|
Aktiv komparator: 1
|
contact lens care system
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
High Contrast Visual Acuity
Tidsramme: 2 weeks
|
High Contrast Visual Acuity with contact lenses, was measured using standardized and computer generated logMAR chart. 10 Sloan letters adopted. VA chart's target size varied from logMAR 1.0 to -0.40 in 0.1 logMAR step. |
2 weeks
|
|
Low Contrast Visual Acuity
Tidsramme: 2 weeks
|
Low Contrast Visual Acuity with contact lenses, was measured using standardized and computer generated logMAR chart. 10 Sloan letters adopted. VA chart's target size varied from logMAR 1.0 to -0.40 in 0.1 logMAR step. |
2 weeks
|
|
In-vivo Wettability
Tidsramme: 2 weeks
|
Pre-lens non-invasive tear breakup time
|
2 weeks
|
|
Subjective Comfort Rating
Tidsramme: 2 weeks
|
Numeric rating scale was administered.
Comfort ratings (0 - 100), 0 = Very poor comfort and 100 = Excellent comfort.
|
2 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Desmond Fonn, M. Optom, University of Waterloo
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P/265/07/L
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .